These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
308 related articles for article (PubMed ID: 36551260)
1. The Potential Roles of Post-Translational Modifications of PPARγ in Treating Diabetes. Ji X; Zhang W; Yin L; Shi Z; Luan J; Chen L; Liu L Biomolecules; 2022 Dec; 12(12):. PubMed ID: 36551260 [TBL] [Abstract][Full Text] [Related]
2. Controlling a master switch of adipocyte development and insulin sensitivity: covalent modifications of PPARγ. Floyd ZE; Stephens JM Biochim Biophys Acta; 2012 Jul; 1822(7):1090-5. PubMed ID: 22504298 [TBL] [Abstract][Full Text] [Related]
3. New approach in the treatment of T2DM and metabolic syndrome (focus on a novel insulin sensitizer). Tjokroprawiro A Acta Med Indones; 2006; 38(3):160-6. PubMed ID: 17119268 [TBL] [Abstract][Full Text] [Related]
4. PPARγ signaling and metabolism: the good, the bad and the future. Ahmadian M; Suh JM; Hah N; Liddle C; Atkins AR; Downes M; Evans RM Nat Med; 2013 May; 19(5):557-66. PubMed ID: 23652116 [TBL] [Abstract][Full Text] [Related]
5. Peroxisome proliferator-activated receptor gamma agonists as insulin sensitizers: from the discovery to recent progress. Cho N; Momose Y Curr Top Med Chem; 2008; 8(17):1483-507. PubMed ID: 19075761 [TBL] [Abstract][Full Text] [Related]
6. Pleiotropic effects of PPARγ agonist on hemostatic activation in type 2 diabetes mellitus. Ferroni P; Della-Morte D; Pileggi A; Riondino S; Rundek T; Ricordi C; Guadagni F Curr Vasc Pharmacol; 2013 May; 11(3):338-51. PubMed ID: 23650948 [TBL] [Abstract][Full Text] [Related]
7. PPARγ signaling and emerging opportunities for improved therapeutics. Wang S; Dougherty EJ; Danner RL Pharmacol Res; 2016 Sep; 111():76-85. PubMed ID: 27268145 [TBL] [Abstract][Full Text] [Related]
8. Revisiting PPARγ as a target for the treatment of metabolic disorders. Choi SS; Park J; Choi JH BMB Rep; 2014 Nov; 47(11):599-608. PubMed ID: 25154720 [TBL] [Abstract][Full Text] [Related]
9. Advances on PPARγ Research in the Emerging Era of Precision Medicine. Lu P; Zhao Z Curr Drug Targets; 2018; 19(6):663-673. PubMed ID: 28641522 [TBL] [Abstract][Full Text] [Related]
12. [Recent trends in PPARgamma agonist development of thiazolidinediones and non-thiazolidinediones]. Tanaka T Nihon Rinsho; 2010 Feb; 68(2):249-55. PubMed ID: 20158092 [TBL] [Abstract][Full Text] [Related]
13. Thiazolidinediones and the promise of insulin sensitization in type 2 diabetes. Soccio RE; Chen ER; Lazar MA Cell Metab; 2014 Oct; 20(4):573-91. PubMed ID: 25242225 [TBL] [Abstract][Full Text] [Related]